Skip to main content


Page 302 of 312

  1. Activation of caspase-9 in response to treatment with cytotoxic drugs is inhibited in NSCLC cells, which may contribute to the clinical resistance to chemotherapy shown in this type of tumor. The aim of the pr...

    Authors: Agnieszka Checinska, Giuseppe Giaccone, Bas SJ Hoogeland, Carlos G Ferreira, Jose A Rodriguez and Frank AE Kruyt
    Citation: BMC Cancer 2006 6:166
  2. The association of nipple discharge with breast carcinoma has resulted in numerous women undergoing exploratory surgery to exclude malignancy. The aim of this study was to determine whether pre-operative facto...

    Authors: Mary F Dillon, Shah R Mohd Nazri, Shaaira Nasir, Enda W McDermott, Denis Evoy, Thomas B Crotty, Niall O'Higgins and Arnold DK Hill
    Citation: BMC Cancer 2006 6:164
  3. In selected patients with peritoneal carcinomatosis from colorectal cancer prognosis can be improved by hyperthermic intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery. The aim of this study was ...

    Authors: Joerg OW Pelz, J Doerfer, A Dimmler, W Hohenberger and T Meyer
    Citation: BMC Cancer 2006 6:162
  4. In multiple myeloma (MM), increased neoangiogenesis contributes to tumor growth and disease progression. Increased levels of endothelial progenitor cells (EPCs) contribute to neoangiogenesis in MM, and, import...

    Authors: Marc Braunstein, Tayfun Özçelik, Sevgi Bağişlar, Varsha Vakil, Eric LP Smith, Kezhi Dai, Cemaliye B Akyerli and Olcay A Batuman
    Citation: BMC Cancer 2006 6:161
  5. The risk of metastasis and the survival in patients with primary extremity soft tissue sarcomas is worse when tumour size is large and the grade of malignancy is high. Such tumours may receive chemotherapy and...

    Authors: Benedikt Leidinger, Thomas Heyse, Andreas Schuck, Horst Buerger, Philipp Mommsen, Thomas Bruening, Susanne Fuchs and Georg Gosheger
    Citation: BMC Cancer 2006 6:160
  6. Previous studies on bladder cancer have shown nodal involvement to be an independent indicator of prognosis and survival. This study aimed at developing an objective method for detection of nodal metastasis fr...

    Authors: Anirban P Mitra, Arpit A Almal, Ben George, David W Fry, Peter F Lenehan, Vincenzo Pagliarulo, Richard J Cote, Ram H Datar and William P Worzel
    Citation: BMC Cancer 2006 6:159
  7. C/EBPα is a transcription factor essential for terminal differentiation of several cell types. It has not known if C/EBPα protein is expressed and functions in the prostate gland.

    Authors: Hong Yin, Hanna S Radomska, Daniel G Tenen and Jonathan Glass
    Citation: BMC Cancer 2006 6:158
  8. It is widely accepted that vulvar carcinoma with a depth of invasion of less than one millimeter is sufficiently treated by vulvectomy or wide local excision without inguinal lymphadenectomy.

    Authors: Jutta Sidor, Raihana Diallo-Danebrock, Elke Eltze and Ralph J Lellé
    Citation: BMC Cancer 2006 6:157
  9. Breast cancer in men is an infrequent occurrence, accounting for ~1% of all breast tumors with an incidence of about 1:100,000. The relative rarity of male breast cancer (MBC) limits our understanding of the e...

    Authors: GianMaria Miolo, Lara Della Puppa, Manuela Santarosa, Clelia De Giacomi, Andrea Veronesi, Ettore Bidoli, Maria Grazia Tibiletti, Alessandra Viel and Riccardo Dolcetti
    Citation: BMC Cancer 2006 6:156
  10. GSAO (4-[N-[S-glutathionylacetyl]amino] phenylarsenoxide) is a hydrophilic derivative of the protein tyrosine phosphatase inhibitor phenylarsine oxide (PAO). It inhibits angiogenesis and tumour growth in mouse...

    Authors: Verity A Cadd, Philip J Hogg, Adrian L Harris and Stephan M Feller
    Citation: BMC Cancer 2006 6:155
  11. TSPY is a repeated gene mapped to the critical region harboring the gonadoblastoma locus on the Y chromosome (GBY), the only oncogenic locus on this male-specific chromosome. Elevated levels of TSPY have been ...

    Authors: Shane W Oram, Xing Xing Liu, Tin-Lap Lee, Wai-Yee Chan and Yun-Fai Chris Lau
    Citation: BMC Cancer 2006 6:154
  12. There is a lack of clinical data on the validity of neoadjuvant chemotherapy in the treatment of ovarian cancer. The aim of this study was to compare the impact of the adjuvant and neoadjuvant chemotherapy reg...

    Authors: Arturas Inciura, Andrius Simavicius, Elona Juozaityte, Juozas Kurtinaitis, Ruta Nadisauskiene, Eimantas Svedas and Skirmantas Kajenas
    Citation: BMC Cancer 2006 6:153
  13. The role of exogenous hormone exposures in the development of meningioma is unclear, but these exposures have been proposed as one hypothesis to explain the over-abundance of such tumors in women.

    Authors: Brian Custer, WT Longstreth Jr, Leslie E Phillips, Thomas D Koepsell and Gerald Van Belle
    Citation: BMC Cancer 2006 6:152
  14. Non-small cell lung cancer is the most common cause of early casualty from malignant disease in western countries. The heterogeneous nature of these cells has been identified by histochemical and microarray bi...

    Authors: Sandra YY Fok, Jeffrey S Rubin, Fiona Pixley, John Condeelis, Filip Braet and Lilian L Soon
    Citation: BMC Cancer 2006 6:151

    The Erratum to this article has been published in BMC Cancer 2007 7:32

  15. Studies indicate that thymidylate synthase (TS) expression, p53 and mismatch repair status have potential to influence colorectal cancer (CRC) outcome. There is, however, little data on the inter-relationship ...

    Authors: Sanjay Popat, Richard Wort and Richard S Houlston
    Citation: BMC Cancer 2006 6:150
  16. Upregulation of endogenous angiostatin levels may constitute a novel anti-angiogenic, and therefore anti-tumor therapy. In vitro, angiostatin generation is a two-step process, starting with the conversion of plas...

    Authors: Renate RJ de Groot-Besseling, Theo JM Ruers, Iris L Lamers-Elemans, Cathy N Maass, Robert MW de Waal and Johan R Westphal
    Citation: BMC Cancer 2006 6:149
  17. Increasing evidence from epidemiologic studies suggest that oxidative stress may play a role in adult glioma. In addition to dietary antioxidants, antioxidant and weak estrogenic properties of dietary phytoest...

    Authors: Nicole Tedeschi-Blok, Marion Lee, Jennette D Sison, Rei Miike and Margaret Wrensch
    Citation: BMC Cancer 2006 6:148
  18. Abnormal hemostasis in cancer patients has previously been described, however the correlation between the plasma fibrinogen level and cancer metastasis and prognosis has not been reported in a large-scale clin...

    Authors: Hiroharu Yamashita, Joji Kitayama, Nobuko Kanno, Yutaka Yatomi and Hirokazu Nagawa
    Citation: BMC Cancer 2006 6:147
  19. Very few reports have investigated the role of cell cycle regulators as biomarkers in Basaloid Squamous Cell Carcinoma (BSCC) of the larynx, a definite morphologic, uncommon, very aggressive variant of squamou...

    Authors: Grazia Salerno, Dolores Di Vizio, Stefania Staibano, Giampiero Mottola, Giuseppe Quaremba, Massimo Mascolo, Vieri Galli, Gaetano De Rosa and Luigi Insabato
    Citation: BMC Cancer 2006 6:146
  20. Ephrin receptor B2 (EPHB2) has recently been proposed as a novel tumor suppressor gene in colorectal cancer (CRC). Inactivation of the gene has been shown to correlate with progression of colorectal tumorigenesi...

    Authors: Antti Kokko, Päivi Laiho, Rainer Lehtonen, Sanna Korja, Luis G Carvajal-Carmona, Heikki Järvinen, Jukka-Pekka Mecklin, Charis Eng, Johanna Schleutker, Ian PM Tomlinson, Pia Vahteristo and Lauri A Aaltonen
    Citation: BMC Cancer 2006 6:145
  21. Increased expression of Eph receptor tyrosine kinases and their ephrin ligands has been implicated in tumor progression in a number of malignancies. This report describes aberrant expression of these genes in ...

    Authors: Nirmitha I Herath, Mark D Spanevello, Sabe Sabesan, Tanya Newton, Margaret Cummings, Shannon Duffy, Douglas Lincoln, Glen Boyle, Peter G Parsons and Andrew W Boyd
    Citation: BMC Cancer 2006 6:144
  22. Gemcitabine (dFdC) is an active antitumour agent with radiosensitising properties, shown both in preclinical and clinical studies. In the present study, the relation between deoxycytidine kinase (dCK) activity...

    Authors: Bea Pauwels, Annelies EC Korst, Greet GO Pattyn, Hilde AJ Lambrechts, Juliette AE Kamphuis, Christel MJ De Pooter, Godefridus J Peters, Filip Lardon and Jan B Vermorken
    Citation: BMC Cancer 2006 6:142
  23. Human studies of dietary fat as a possible risk factor for cutaneous malignant melanoma (CMM) and non-melanoma skin cancer (NMSC) – principally basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) – ha...

    Authors: Robert H Granger, Leigh Blizzard, Jayne L Fryer and Terence Dwyer
    Citation: BMC Cancer 2006 6:141
  24. Thrombospondin-1 (TSP-1) is an extracellular matrix component glycoprotein, which is known to be a potent inhibitor of angiogenesis and may be important in cancer invasiveness. We examined the TSP-1 expression...

    Authors: E Ioachim, MC Michael, M Salmas, K Damala, E Tsanou, MM Michael, V Malamou-Mitsi and NE Stavropoulos
    Citation: BMC Cancer 2006 6:140
  25. The highest rates of esophageal squamous cell carcinoma (ESCC) in Brazil occur in Rio Grande do Sul, the most southern state, which has incidence rates of 20.4/100,000/year for men and 6.5/100,000/year for wom...

    Authors: Renato B Fagundes, Christian C Abnet, Paul T Strickland, Farin Kamangar, Mark J Roth, Philip R Taylor and Sanford M Dawsey
    Citation: BMC Cancer 2006 6:139
  26. Accumulative evidence suggests that low folate intake is associated with increased risk of breast cancer. Polymorphisms in genes involved in folate metabolism may influence DNA methylation, nucleotide synthesi...

    Authors: Xiangjun Zhai, Jun Gao, Zhibin Hu, Jinhai Tang, Jianwei Qin, Shui Wang, Xuechen Wang, Guangfu Jin, Jiyong Liu, Wenshen Chen, Feng Chen, Xinru Wang, Qingyi Wei and Hongbing Shen
    Citation: BMC Cancer 2006 6:138
  27. Many emerging new drugs have recently been trialled for treatment of early and advanced breast cancer. Among these new agents paclitaxel and gemcitabine play a crucial role, mostly in patients with relapsed an...

    Authors: Silverio Tomao, Adriana Romiti, Federica Tomao, Marisa Di Seri, Giuliana Caprio, Gian Paolo Spinelli, Edmondo Terzoli and Luigi Frati
    Citation: BMC Cancer 2006 6:137
  28. The aim of this study is to compare the cost-effectiveness of screening with stool DNA testing with that of screening with other tools (annual fecal occult blood testing, flexible sigmoidoscopy every 5 years, ...

    Authors: Grace Hui-Min Wu, Yi-Ming Wang, Amy Ming-Fang Yen, Jau-Min Wong, Hsin-Chih Lai, Jane Warwick and Tony Hsiu-Hsi Chen
    Citation: BMC Cancer 2006 6:136
  29. Cervical cancer and infection with human immunodeficiency virus (HIV) are both major public health problems in South Africa. The aim of this study was to determine the risk of cervical pre-cancer and cancer am...

    Authors: Jennifer R Moodley, Margaret Hoffman, Henri Carrara, Bruce R Allan, Diane D Cooper, Lynn Rosenberg, Lynette E Denny, Samuel Shapiro and Anna-Lise Williamson
    Citation: BMC Cancer 2006 6:135
  30. COX-2 expression in tumour cells has been associated with poor prognosis in gastrointestinal and non-gastrointestinal cancers. The aim of our study was to test the hypothesis that higher levels of COX-2 expres...

    Authors: Pradeep Bhandari, Adrian C Bateman, Raj L Mehta, Bernard SF Stacey, Penny Johnson, Ian A Cree, Federica Di Nicolantonio and Praful Patel
    Citation: BMC Cancer 2006 6:134
  31. The implementation of combined radiochemotherapy (RCHT) with temozolomide (TMZ) has lead to a significant increase in overall survival times in patients with Glioblastoma multiforme (GBM), however, outcome sti...

    Authors: Stephanie E Combs, Steffen Heeger, Renate Haselmann, Lutz Edler, Jürgen Debus and Daniela Schulz-Ertner
    Citation: BMC Cancer 2006 6:133
  32. Expression of folylpoly-γ-glutamate synthetase (FPGS) gene is two- to three-fold higher in B-precursor ALL (Bp- ALL) than in T-lineage ALL (T-ALL) and correlates with intracellular accumulation of methotrexate...

    Authors: Guy J Leclerc, Gilles M Leclerc, Ting Ting Hsieh Kinser and Julio C Barredo
    Citation: BMC Cancer 2006 6:132
  33. Germline mutations in RET are responsible for multiple endocrine neoplasia type 2 (MEN2), an autosomal dominantly inherited cancer syndrome that is characterized by medullary thyroid carcinoma (MTC), pheochromocy...

    Authors: Christian A Koch, Frederieke M Brouwers, Alexander O Vortmeyer, Andrea Tannapfel, Steven K Libutti, Zhengping Zhuang, Karel Pacak, Hartmut PH Neumann and Ralf Paschke
    Citation: BMC Cancer 2006 6:131
  34. Malignant pleural mesothelioma (MPM) is a tumor known to be resistant to conventional therapies. Thus, an in vivo model can represent an important tool for assessing the efficacy of novel approaches in the tre...

    Authors: Daniele Martarelli, Alfonso Catalano, Antonio Procopio, Sara Orecchia, Roberta Libener and Giorgio Santoni
    Citation: BMC Cancer 2006 6:130
  35. Bortezomib (Velcade®), a dipeptide boronate proteasome inhibitor, is a novel anti-cancer agent registered for multiple myeloma (MM). It has also shown promising clinical activity in non-small cell lung cancer (NS...

    Authors: Jens Voortman and Giuseppe Giaccone
    Citation: BMC Cancer 2006 6:129
  36. Low-dose Cisplatin and Interferon alpha treatment of solid tumors rarely has been associated with severe hypocalcaemia. To the authors knowledge the phenomenon has not been reported previously in patients with...

    Authors: Katrin Hoffmann, Angela Marten, Katja Lindel, Stefan Fritz, Dirk Jager, Markus W Buchler and Jan Schmidt
    Citation: BMC Cancer 2006 6:128
  37. Leiomyomatosis peritonealis disseminata (LPD) is a rare disease in which multiple smooth muscle or smooth muscle-like nodules develop subperitoneally in any part of the abdominal cavity. No reports of multiple...

    Authors: Carmine Nappi, Attilio Di Spiezio Sardo, Vincenzo Dario Mandato, Giuseppe Bifulco, Elisa Merello, Antonio Savanelli, Chiara Mignogna, Valeria Capra and Maurizio Guida
    Citation: BMC Cancer 2006 6:127
  38. Elderly patients have been often excluded from or underrepresented in the study populations of combination chemotherapy trials. The primary end point of this study was to determine the response rate and the to...

    Authors: D Santini, F Graziano, V Catalano, M Di Seri, E Testa, AM Baldelli, P Giordani, A La Cesa, B Spalletta, B Vincenzi, A Russo, M Caraglia, V Virzi, S Cascinu and G Tonini
    Citation: BMC Cancer 2006 6:125
  39. In previous analyses we identified therapy-induced upregulation of the CDK inhibitor p21CIP/WAF-1 and consequently decreased tumor cell proliferation or loss of Bax as adverse factors for survival in rectal cance...

    Authors: Isrid Sturm, Beate Rau, Peter M Schlag, Peter Wust, Bert Hildebrandt, Hanno Riess, Steffen Hauptmann, Bernd Dörken and Peter T Daniel
    Citation: BMC Cancer 2006 6:124
  40. Conflicting data exist about the prevalence of HER-2/neu overexpression in colorectal cancer ranging from 0 to 83 %. In our study we tried to clarify the extent of expression and its relationship to clinicopat...

    Authors: B Schuell, T Gruenberger, W Scheithauer, Ch Zielinski and F Wrba
    Citation: BMC Cancer 2006 6:123
  41. Even today, treatment of Stage III NSCLC still poses a serious challenge. So far, surgical resection is the treatment of choice. Patients whose tumour is not resectable or who are unfit to undergo surgery are ...

    Authors: AD Jensen, MW Münter, H Bischoff, R Haselmann, C Timke, R Krempien, F Sterzing, S Nill, S Heeger, A Hoess, U Haberkorn, PE Huber, M Steins, M Thomas, J Debus and KK Herfarth
    Citation: BMC Cancer 2006 6:122
  42. Unresectable biliary tract carcinoma is known to demonstrate a poor prognosis. We conducted a single arm phase II study of LFP therapy (5-FU (5-fluorourasil) continuous infusion (CVI) and Low-dose consecutive ...

    Authors: Kazuma Kobayashi, Akihito Tsuji, Sojiro Morita, Tadashi Horimi, Tetsuhiko Shirasaka and Takashi Kanematsu
    Citation: BMC Cancer 2006 6:121
  43. Advances in molecular biology and growing requirements from biomarker validation studies have generated a need for tissue banks to provide quality-controlled tissue samples with standardized clinical annotatio...

    Authors: Ashokkumar A Patel, John R Gilbertson, Anil V Parwani, Rajiv Dhir, Milton W Datta, Rajnish Gupta, Jules J Berman, Jonathan Melamed, Andre Kajdacsy-Balla, Jan Orenstein and Michael J Becich
    Citation: BMC Cancer 2006 6:120
  44. Phytopharmacological studies of different Calendula extracts have shown anti-inflamatory, anti-viral and anti-genotoxic properties of therapeutic interest. In this study, we evaluated the in vitro cytotoxic anti-...

    Authors: Eva Jiménez-Medina, Angel Garcia-Lora, Laura Paco, Ignacio Algarra, Antonia Collado and Federico Garrido
    Citation: BMC Cancer 2006 6:119
  45. Solitary plasmacytoma (SP) of the bone is a rare plasma-cell neoplasm. There are no conclusive data in the literature on the optimal radiation therapy (RT) dose in SP. Therefore, in this large retrospective st...

    Authors: David Knobel, Abderrahim Zouhair, Richard W Tsang, Philip Poortmans, Yazid Belkacémi, Michel Bolla, Fazilet Dinçbas Oner, Christine Landmann, Bernard Castelain and Mahmut Ozsahin
    Citation: BMC Cancer 2006 6:118
  46. Primary pancreatic lymphomas (PPL) are rare tumours of the pancreas. Symptoms, imaging and tumour markers can mimic pancreatic adenocarcinoma, but they are much more amenable to treatment. Treatment for PPL re...

    Authors: Peter S Grimison, Melvin T Chin, Michelle L Harrison and David Goldstein
    Citation: BMC Cancer 2006 6:117

Featured videos

View featured videos from across the BMC-series journals